HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer.

J Leukoc Biol · 2026 · PMC13017059 · PMID 41777114

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Total HER2 protein rose as early as 1 h postirradiation but did not reach statistical significance until 4 h ( Fig. 3D, E ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.